img

Global Acne Vulgaris Management Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Acne Vulgaris Management Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Acne Vulgaris Management report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acne Vulgaris Management market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Acne Vulgaris Management industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Acne Vulgaris Management key companies include Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc and Helix BioMedix Inc, etc. Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc are top 3 players and held % share in total in 2022.
Acne Vulgaris Management can be divided into CB-0601, CJM-112, CLS-007 and Dapsone, etc. CB-0601 is the mainstream product in the market, accounting for % share globally in 2022.
Acne Vulgaris Management is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Acne Vulgaris Management industry development. In 2022, global % share of Acne Vulgaris Management went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acne Vulgaris Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Segment by Type
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others

Segment by Application


Clinic
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acne Vulgaris Management market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Acne Vulgaris Management introduction, etc. Acne Vulgaris Management Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Acne Vulgaris Management market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Acne Vulgaris Management
1.1 Acne Vulgaris Management Market Overview
1.1.1 Acne Vulgaris Management Product Scope
1.1.2 Acne Vulgaris Management Market Status and Outlook
1.2 Global Acne Vulgaris Management Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Acne Vulgaris Management Market Size by Region (2018-2033)
1.4 Global Acne Vulgaris Management Historic Market Size by Region (2018-2023)
1.5 Global Acne Vulgaris Management Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Acne Vulgaris Management Market Size (2018-2033)
1.6.1 North America Acne Vulgaris Management Market Size (2018-2033)
1.6.2 Europe Acne Vulgaris Management Market Size (2018-2033)
1.6.3 Asia-Pacific Acne Vulgaris Management Market Size (2018-2033)
1.6.4 Latin America Acne Vulgaris Management Market Size (2018-2033)
1.6.5 Middle East & Africa Acne Vulgaris Management Market Size (2018-2033)
2 Acne Vulgaris Management Market by Type
2.1 Introduction
2.1.1 CB-0601
2.1.2 CJM-112
2.1.3 CLS-007
2.1.4 Dapsone
2.1.5 DFD-10
2.1.6 DLX-2323
2.1.7 Others
2.2 Global Acne Vulgaris Management Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Acne Vulgaris Management Historic Market Size by Type (2018-2023)
2.2.2 Global Acne Vulgaris Management Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Acne Vulgaris Management Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Acne Vulgaris Management Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Acne Vulgaris Management Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Acne Vulgaris Management Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Acne Vulgaris Management Revenue Breakdown by Type (2018-2033)
3 Acne Vulgaris Management Market Overview by Application
3.1 Introduction
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Acne Vulgaris Management Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Acne Vulgaris Management Historic Market Size by Application (2018-2023)
3.2.2 Global Acne Vulgaris Management Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Acne Vulgaris Management Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Acne Vulgaris Management Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Acne Vulgaris Management Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Acne Vulgaris Management Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Acne Vulgaris Management Revenue Breakdown by Application (2018-2033)
4 Acne Vulgaris Management Competition Analysis by Players
4.1 Global Acne Vulgaris Management Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acne Vulgaris Management as of 2022)
4.3 Date of Key Players Enter into Acne Vulgaris Management Market
4.4 Global Top Players Acne Vulgaris Management Headquarters and Area Served
4.5 Key Players Acne Vulgaris Management Product Solution and Service
4.6 Competitive Status
4.6.1 Acne Vulgaris Management Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Common Pharma Inc
5.1.1 Common Pharma Inc Profile
5.1.2 Common Pharma Inc Main Business
5.1.3 Common Pharma Inc Acne Vulgaris Management Products, Services and Solutions
5.1.4 Common Pharma Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.1.5 Common Pharma Inc Recent Developments
5.2 Cutanea Life Sciences Inc
5.2.1 Cutanea Life Sciences Inc Profile
5.2.2 Cutanea Life Sciences Inc Main Business
5.2.3 Cutanea Life Sciences Inc Acne Vulgaris Management Products, Services and Solutions
5.2.4 Cutanea Life Sciences Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.2.5 Cutanea Life Sciences Inc Recent Developments
5.3 Dermira Inc
5.3.1 Dermira Inc Profile
5.3.2 Dermira Inc Main Business
5.3.3 Dermira Inc Acne Vulgaris Management Products, Services and Solutions
5.3.4 Dermira Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.3.5 ELORAC Inc Recent Developments
5.4 ELORAC Inc
5.4.1 ELORAC Inc Profile
5.4.2 ELORAC Inc Main Business
5.4.3 ELORAC Inc Acne Vulgaris Management Products, Services and Solutions
5.4.4 ELORAC Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.4.5 ELORAC Inc Recent Developments
5.5 Ensol Biosciences Inc
5.5.1 Ensol Biosciences Inc Profile
5.5.2 Ensol Biosciences Inc Main Business
5.5.3 Ensol Biosciences Inc Acne Vulgaris Management Products, Services and Solutions
5.5.4 Ensol Biosciences Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.5.5 Ensol Biosciences Inc Recent Developments
5.6 Foamix Pharmaceuticals Ltd
5.6.1 Foamix Pharmaceuticals Ltd Profile
5.6.2 Foamix Pharmaceuticals Ltd Main Business
5.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Management Products, Services and Solutions
5.6.4 Foamix Pharmaceuticals Ltd Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.6.5 Foamix Pharmaceuticals Ltd Recent Developments
5.7 Galderma SA
5.7.1 Galderma SA Profile
5.7.2 Galderma SA Main Business
5.7.3 Galderma SA Acne Vulgaris Management Products, Services and Solutions
5.7.4 Galderma SA Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.7.5 Galderma SA Recent Developments
5.8 GlaxoSmithKline Plc
5.8.1 GlaxoSmithKline Plc Profile
5.8.2 GlaxoSmithKline Plc Main Business
5.8.3 GlaxoSmithKline Plc Acne Vulgaris Management Products, Services and Solutions
5.8.4 GlaxoSmithKline Plc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.8.5 GlaxoSmithKline Plc Recent Developments
5.9 Helix BioMedix Inc
5.9.1 Helix BioMedix Inc Profile
5.9.2 Helix BioMedix Inc Main Business
5.9.3 Helix BioMedix Inc Acne Vulgaris Management Products, Services and Solutions
5.9.4 Helix BioMedix Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.9.5 Helix BioMedix Inc Recent Developments
5.10 Hovione FarmaCiencia SA
5.10.1 Hovione FarmaCiencia SA Profile
5.10.2 Hovione FarmaCiencia SA Main Business
5.10.3 Hovione FarmaCiencia SA Acne Vulgaris Management Products, Services and Solutions
5.10.4 Hovione FarmaCiencia SA Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.10.5 Hovione FarmaCiencia SA Recent Developments
5.11 Lee's Pharmaceutical Holdings Ltd
5.11.1 Lee's Pharmaceutical Holdings Ltd Profile
5.11.2 Lee's Pharmaceutical Holdings Ltd Main Business
5.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Management Products, Services and Solutions
5.11.4 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.11.5 Lee's Pharmaceutical Holdings Ltd Recent Developments
5.12 LEO Pharma A/S
5.12.1 LEO Pharma A/S Profile
5.12.2 LEO Pharma A/S Main Business
5.12.3 LEO Pharma A/S Acne Vulgaris Management Products, Services and Solutions
5.12.4 LEO Pharma A/S Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.12.5 LEO Pharma A/S Recent Developments
5.13 Novabiotics Ltd
5.13.1 Novabiotics Ltd Profile
5.13.2 Novabiotics Ltd Main Business
5.13.3 Novabiotics Ltd Acne Vulgaris Management Products, Services and Solutions
5.13.4 Novabiotics Ltd Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.13.5 Novabiotics Ltd Recent Developments
5.14 Novan Inc
5.14.1 Novan Inc Profile
5.14.2 Novan Inc Main Business
5.14.3 Novan Inc Acne Vulgaris Management Products, Services and Solutions
5.14.4 Novan Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.14.5 Novan Inc Recent Developments
5.15 Novartis AG
5.15.1 Novartis AG Profile
5.15.2 Novartis AG Main Business
5.15.3 Novartis AG Acne Vulgaris Management Products, Services and Solutions
5.15.4 Novartis AG Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.15.5 Novartis AG Recent Developments
5.16 Paratek Pharmaceuticals Inc
5.16.1 Paratek Pharmaceuticals Inc Profile
5.16.2 Paratek Pharmaceuticals Inc Main Business
5.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Management Products, Services and Solutions
5.16.4 Paratek Pharmaceuticals Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.16.5 Paratek Pharmaceuticals Inc Recent Developments
5.17 Pfizer Inc
5.17.1 Pfizer Inc Profile
5.17.2 Pfizer Inc Main Business
5.17.3 Pfizer Inc Acne Vulgaris Management Products, Services and Solutions
5.17.4 Pfizer Inc Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.17.5 Pfizer Inc Recent Developments
5.18 Phosphagenics Ltd
5.18.1 Phosphagenics Ltd Profile
5.18.2 Phosphagenics Ltd Main Business
5.18.3 Phosphagenics Ltd Acne Vulgaris Management Products, Services and Solutions
5.18.4 Phosphagenics Ltd Acne Vulgaris Management Revenue (US$ Million) & (2018-2023)
5.18.5 Phosphagenics Ltd Recent Developments
6 North America
6.1 North America Acne Vulgaris Management Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Acne Vulgaris Management Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acne Vulgaris Management Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acne Vulgaris Management Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acne Vulgaris Management Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acne Vulgaris Management Market Dynamics
11.1 Acne Vulgaris Management Industry Trends
11.2 Acne Vulgaris Management Market Drivers
11.3 Acne Vulgaris Management Market Challenges
11.4 Acne Vulgaris Management Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Acne Vulgaris Management Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Acne Vulgaris Management Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Acne Vulgaris Management Market Size Share by Region (2018-2023)
Table 4. Global Acne Vulgaris Management Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Acne Vulgaris Management Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Acne Vulgaris Management Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Acne Vulgaris Management Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Acne Vulgaris Management Revenue Market Share by Type (2018-2023)
Table 9. Global Acne Vulgaris Management Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Acne Vulgaris Management Revenue Market Share by Type (2024-2033)
Table 11. North America Acne Vulgaris Management Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Acne Vulgaris Management Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Acne Vulgaris Management Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Acne Vulgaris Management Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Acne Vulgaris Management Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Acne Vulgaris Management Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Acne Vulgaris Management Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Acne Vulgaris Management Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Acne Vulgaris Management Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Acne Vulgaris Management Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Acne Vulgaris Management Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Acne Vulgaris Management Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Acne Vulgaris Management Revenue Market Share by Application (2018-2023)
Table 24. Global Acne Vulgaris Management Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Acne Vulgaris Management Revenue Market Share by Application (2024-2033)
Table 26. North America Acne Vulgaris Management Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Acne Vulgaris Management Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Acne Vulgaris Management Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Acne Vulgaris Management Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Acne Vulgaris Management Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Acne Vulgaris Management Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Acne Vulgaris Management Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Acne Vulgaris Management Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Acne Vulgaris Management Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Acne Vulgaris Management Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Acne Vulgaris Management Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Acne Vulgaris Management Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acne Vulgaris Management as of 2022)
Table 39. Date of Key Players Enter into Acne Vulgaris Management Market
Table 40. Global Acne Vulgaris Management Key Players Headquarters and Area Served
Table 41. Acne Vulgaris Management Product Solution and Service
Table 42. Global Acne Vulgaris Management Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Common Pharma Inc Basic Information List
Table 45. Common Pharma Inc Description and Business Overview
Table 46. Common Pharma Inc Acne Vulgaris Management Products, Services and Solutions
Table 47. Revenue (US$ Million) in Acne Vulgaris Management Business of Common Pharma Inc (2018-2023)
Table 48. Common Pharma Inc Recent Developments
Table 49. Cutanea Life Sciences Inc Basic Information List
Table 50. Cutanea Life Sciences Inc Description and Business Overview
Table 51. Cutanea Life Sciences Inc Acne Vulgaris Management Products, Services and Solutions
Table 52. Revenue (US$ Million) in Acne Vulgaris Management Business of Cutanea Life Sciences Inc (2018-2023)
Table 53. Cutanea Life Sciences Inc Recent Developments
Table 54. Dermira Inc Basic Information List
Table 55. Dermira Inc Description and Business Overview
Table 56. Dermira Inc Acne Vulgaris Management Products, Services and Solutions
Table 57. Revenue (US$ Million) in Acne Vulgaris Management Business of Dermira Inc (2018-2023)
Table 58. Dermira Inc Recent Developments
Table 59. ELORAC Inc Basic Information List
Table 60. ELORAC Inc Description and Business Overview
Table 61. ELORAC Inc Acne Vulgaris Management Products, Services and Solutions
Table 62. Revenue (US$ Million) in Acne Vulgaris Management Business of ELORAC Inc (2018-2023)
Table 63. ELORAC Inc Recent Developments
Table 64. Ensol Biosciences Inc Basic Information List
Table 65. Ensol Biosciences Inc Description and Business Overview
Table 66. Ensol Biosciences Inc Acne Vulgaris Management Products, Services and Solutions
Table 67. Revenue (US$ Million) in Acne Vulgaris Management Business of Ensol Biosciences Inc (2018-2023)
Table 68. Ensol Biosciences Inc Recent Developments
Table 69. Foamix Pharmaceuticals Ltd Basic Information List
Table 70. Foamix Pharmaceuticals Ltd Description and Business Overview
Table 71. Foamix Pharmaceuticals Ltd Acne Vulgaris Management Products, Services and Solutions
Table 72. Revenue (US$ Million) in Acne Vulgaris Management Business of Foamix Pharmaceuticals Ltd (2018-2023)
Table 73. Foamix Pharmaceuticals Ltd Recent Developments
Table 74. Galderma SA Basic Information List
Table 75. Galderma SA Description and Business Overview
Table 76. Galderma SA Acne Vulgaris Management Products, Services and Solutions
Table 77. Revenue (US$ Million) in Acne Vulgaris Management Business of Galderma SA (2018-2023)
Table 78. Galderma SA Recent Developments
Table 79. GlaxoSmithKline Plc Basic Information List
Table 80. GlaxoSmithKline Plc Description and Business Overview
Table 81. GlaxoSmithKline Plc Acne Vulgaris Management Products, Services and Solutions
Table 82. Revenue (US$ Million) in Acne Vulgaris Management Business of GlaxoSmithKline Plc (2018-2023)
Table 83. GlaxoSmithKline Plc Recent Developments
Table 84. Helix BioMedix Inc Basic Information List
Table 85. Helix BioMedix Inc Description and Business Overview
Table 86. Helix BioMedix Inc Acne Vulgaris Management Products, Services and Solutions
Table 87. Revenue (US$ Million) in Acne Vulgaris Management Business of Helix BioMedix Inc (2018-2023)
Table 88. Helix BioMedix Inc Recent Developments
Table 89. Hovione FarmaCiencia SA Basic Information List
Table 90. Hovione FarmaCiencia SA Description and Business Overview
Table 91. Hovione FarmaCiencia SA Acne Vulgaris Management Products, Services and Solutions
Table 92. Revenue (US$ Million) in Acne Vulgaris Management Business of Hovione FarmaCiencia SA (2018-2023)
Table 93. Hovione FarmaCiencia SA Recent Developments
Table 94. Lee's Pharmaceutical Holdings Ltd Basic Information List
Table 95. Lee's Pharmaceutical Holdings Ltd Description and Business Overview
Table 96. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Management Products, Services and Solutions
Table 97. Revenue (US$ Million) in Acne Vulgaris Management Business of Lee's Pharmaceutical Holdings Ltd (2018-2023)
Table 98. Lee's Pharmaceutical Holdings Ltd Recent Developments
Table 99. LEO Pharma A/S Basic Information List
Table 100. LEO Pharma A/S Description and Business Overview
Table 101. LEO Pharma A/S Acne Vulgaris Management Products, Services and Solutions
Table 102. Revenue (US$ Million) in Acne Vulgaris Management Business of LEO Pharma A/S (2018-2023)
Table 103. LEO Pharma A/S Recent Developments
Table 104. Novabiotics Ltd Basic Information List
Table 105. Novabiotics Ltd Description and Business Overview
Table 106. Novabiotics Ltd Acne Vulgaris Management Products, Services and Solutions
Table 107. Revenue (US$ Million) in Acne Vulgaris Management Business of Novabiotics Ltd (2018-2023)
Table 108. Novabiotics Ltd Recent Developments
Table 109. Novan Inc Basic Information List
Table 110. Novan Inc Description and Business Overview
Table 111. Novan Inc Acne Vulgaris Management Products, Services and Solutions
Table 112. Revenue (US$ Million) in Acne Vulgaris Management Business of Novan Inc (2018-2023)
Table 113. Novan Inc Recent Developments
Table 114. Novartis AG Basic Information List
Table 115. Novartis AG Description and Business Overview
Table 116. Novartis AG Acne Vulgaris Management Products, Services and Solutions
Table 117. Revenue (US$ Million) in Acne Vulgaris Management Business of Novartis AG (2018-2023)
Table 118. Novartis AG Recent Developments
Table 119. Paratek Pharmaceuticals Inc Basic Information List
Table 120. Paratek Pharmaceuticals Inc Description and Business Overview
Table 121. Paratek Pharmaceuticals Inc Acne Vulgaris Management Products, Services and Solutions
Table 122. Revenue (US$ Million) in Acne Vulgaris Management Business of Paratek Pharmaceuticals Inc (2018-2023)
Table 123. Paratek Pharmaceuticals Inc Recent Developments
Table 124. Pfizer Inc Basic Information List
Table 125. Pfizer Inc Description and Business Overview
Table 126. Pfizer Inc Acne Vulgaris Management Products, Services and Solutions
Table 127. Revenue (US$ Million) in Acne Vulgaris Management Business of Pfizer Inc (2018-2023)
Table 128. Pfizer Inc Recent Developments
Table 129. Phosphagenics Ltd Basic Information List
Table 130. Phosphagenics Ltd Description and Business Overview
Table 131. Phosphagenics Ltd Acne Vulgaris Management Products, Services and Solutions
Table 132. Revenue (US$ Million) in Acne Vulgaris Management Business of Phosphagenics Ltd (2018-2023)
Table 133. Phosphagenics Ltd Recent Developments
Table 134. North America Acne Vulgaris Management Market Size by Country (2018-2023) & (US$ Million)
Table 135. North America Acne Vulgaris Management Market Size by Country (2024-2033) & (US$ Million)
Table 136. Europe Acne Vulgaris Management Market Size by Country (2018-2023) & (US$ Million)
Table 137. Europe Acne Vulgaris Management Market Size by Country (2024-2033) & (US$ Million)
Table 138. Asia-Pacific Acne Vulgaris Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 139. Asia-Pacific Acne Vulgaris Management Market Size by Region (2018-2023) & (US$ Million)
Table 140. Asia-Pacific Acne Vulgaris Management Market Size by Region (2024-2033) & (US$ Million)
Table 141. Asia-Pacific Acne Vulgaris Management Market Share by Region (2018-2023)
Table 142. Asia-Pacific Acne Vulgaris Management Market Share by Region (2024-2033)
Table 143. Latin America Acne Vulgaris Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 144. Latin America Acne Vulgaris Management Market Size by Country (2018-2023) & (US$ Million)
Table 145. Latin America Acne Vulgaris Management Market Size by Country (2024-2033) & (US$ Million)
Table 146. Middle East & Africa Acne Vulgaris Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 147. Middle East & Africa Acne Vulgaris Management Market Size by Country (2018-2023) & (US$ Million)
Table 148. Middle East & Africa Acne Vulgaris Management Market Size by Country (2024-2033) & (US$ Million)
Table 149. Acne Vulgaris Management Market Trends
Table 150. Acne Vulgaris Management Market Drivers
Table 151. Acne Vulgaris Management Market Challenges
Table 152. Acne Vulgaris Management Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acne Vulgaris Management Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Acne Vulgaris Management Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Acne Vulgaris Management Market Share by Regions: 2022 VS 2033
Figure 4. Global Acne Vulgaris Management Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Acne Vulgaris Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Acne Vulgaris Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Acne Vulgaris Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Acne Vulgaris Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Acne Vulgaris Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of CB-0601
Figure 11. Global CB-0601 Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of CJM-112
Figure 13. Global CJM-112 Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of CLS-007
Figure 15. Global CLS-007 Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Dapsone
Figure 17. Global Dapsone Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of DFD-10
Figure 19. Global DFD-10 Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Product Picture of DLX-2323
Figure 21. Global DLX-2323 Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Product Picture of Others
Figure 23. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Global Acne Vulgaris Management Market Size Share by Type: 2022 & 2033
Figure 25. North America Acne Vulgaris Management Revenue Market Share by Type (2018-2033)
Figure 26. Europe Acne Vulgaris Management Revenue Market Share by Type (2018-2033)
Figure 27. Asia-Pacific Acne Vulgaris Management Revenue Market Share by Type (2018-2033)
Figure 28. Latin America Acne Vulgaris Management Revenue Market Share by Type (2018-2033)
Figure 29. Middle East and Africa Acne Vulgaris Management Revenue Market Share by Type (2018-2033)
Figure 30. Clinic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 31. Hospital Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 32. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 33. Global Acne Vulgaris Management Market Size Share by Application: 2022 & 2033
Figure 34. North America Acne Vulgaris Management Revenue Market Share by Application (2018-2033)
Figure 35. Europe Acne Vulgaris Management Revenue Market Share by Application (2018-2033)
Figure 36. Asia-Pacific Acne Vulgaris Management Revenue Market Share by Application (2018-2033)
Figure 37. Latin America Acne Vulgaris Management Revenue Market Share by Application (2018-2033)
Figure 38. Middle East and Africa Acne Vulgaris Management Revenue Market Share by Application (2018-2033)
Figure 39. Acne Vulgaris Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 40. Global Top 5 and Top 10 Players Acne Vulgaris Management Market Share in 2022
Figure 41. North America Acne Vulgaris Management Market Share by Country (2018-2033)
Figure 42. United States Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 43. Canada Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 44. Germany Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 45. France Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 46. U.K. Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 47. Italy Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 48. Russia Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 49. Nordic Countries Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 50. Asia-Pacific Acne Vulgaris Management Market Share by Region (2018-2033)
Figure 51. China Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 52. Japan Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 53. South Korea Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 54. Southeast Asia Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 55. India Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 56. Australia Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 57. Latin America Acne Vulgaris Management Market Share by Country (2018-2033)
Figure 58. Mexico Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 59. Brazil Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 60. Middle East & Africa Acne Vulgaris Management Market Share by Country (2018-2033)
Figure 61. Turkey Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 62. Saudi Arabia Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 63. UAE Acne Vulgaris Management Market Size (2018-2033) & (US$ Million)
Figure 64. Bottom-up and Top-down Approaches for This Report